StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.78−0.11 (-12.27%)

Close on Nov 18, 2026Market cap $43.89MP/E –Yield –

PDS Biotechnology pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

PDS Biotechnology's pe ratio was 39.1× on Oct 31, 2019.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Oct 31, 201939.1×–

More PDS Biotechnology figures

See a number that looks wrong?